↓ Skip to main content

Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion

Overview of attention for article published in Angiogenesis, December 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
238 Dimensions

Readers on

mendeley
203 Mendeley
Title
Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion
Published in
Angiogenesis, December 2011
DOI 10.1007/s10456-011-9241-1
Pubmed ID
Authors

Marco Mineo, Susan H. Garfield, Simona Taverna, Anna Flugy, Giacomo De Leo, Riccardo Alessandro, Elise C. Kohn

Abstract

Exosomes, microvesicles of endocytic origin released by normal and tumor cells, play an important role in cell-to-cell communication. Angiogenesis has been shown to regulate progression of chronic myeloid leukemia (CML). The mechanism through which this happens has not been elucidated. We isolated and characterized exosomes from K562 CML cells and evaluated their effects on human umbilical endothelial cells (HUVECs). Fluorescent-labeled exosomes were internalized by HUVECs during tubular differentiation on Matrigel. Exosome localization was perinuclear early in differentiation, moving peripherally in cells undergoing elongation and connection. Exosomes move within and between nanotubular structures connecting the remodeling endothelial cells. They stimulated angiotube formation over a serum/growth factor-limited medium control, doubling total cumulative tube length (P = 0.003). Treatment of K562 cells with two clinically active tyrosine kinase inhibitors, imatinib and dasatinib, reduced their total exosome release (P < 0.009); equivalent concentrations of drug-treated exosomes induced a similar extent of tubular differentiation. However, dasatinib treatment of HUVECs markedly inhibited HUVEC response to drug control CML exosomes (P < 0.002). In an in vivo mouse Matrigel plug model angiogenesis was induced by K562 exosomes and abrogated by oral dasatinib treatment (P < 0.01). K562 exosomes induced dasatinib-sensitive Src phosphorylation and activation of downstream Src pathway proteins in HUVECs. Imatinib was minimally active against exosome stimulation of HUVEC cell differentiation and signaling. Thus, CML cell-derived exosomes induce angiogenic activity in HUVEC cells. The inhibitory effect of dasatinib on exosome production and vascular differentiation and signaling reveals a key role for Src in both the leukemia and its microenvironment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Spain 2 <1%
France 1 <1%
Uruguay 1 <1%
Belgium 1 <1%
Netherlands 1 <1%
Brazil 1 <1%
Denmark 1 <1%
Unknown 193 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 44 22%
Researcher 39 19%
Student > Doctoral Student 20 10%
Student > Bachelor 19 9%
Student > Master 14 7%
Other 31 15%
Unknown 36 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 59 29%
Biochemistry, Genetics and Molecular Biology 44 22%
Medicine and Dentistry 35 17%
Immunology and Microbiology 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 2%
Other 8 4%
Unknown 44 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2013.
All research outputs
#14,164,797
of 22,701,287 outputs
Outputs from Angiogenesis
#315
of 536 outputs
Outputs of similar age
#153,196
of 243,234 outputs
Outputs of similar age from Angiogenesis
#6
of 9 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 536 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,234 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.